SBC Medical Q2 revenue rises 13% to $49 million; net income attributable up 335%
SBC Medical Group Holdings reported second-quarter 2026 revenue of $49 million, up 13% year over year, and net income attributable to the company of $11 million, up 335%. Over the first half, revenue rose 2% to $92 million, but net income attributable to the company fell 8% to $22 million, so the quarterly gain does not yet show up in the six-month totals.
Key points
- Q2 2026 basic EPS was $0.10, versus $0.02 in Q2 2025; first-half basic EPS was $0.21, down 9% from $0.23.
- Q2 2026 Adjusted EBITDA was $20 million, up 32%, with an Adjusted EBITDA margin of 41%.
- The company said its fee revisions could add approximately $15 million in annual service fees if their impact is realized for a full year.
- As of June 30, 2026, cash and cash equivalents were $184 million; the company also posted investor presentations on August 13, 2026.
The filing
Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.